These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7830855)

  • 21. High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome.
    Wasilewska A; Zoch-Zwierz W; Tobolczyk J; Tenderenda E
    Pediatr Nephrol; 2007 Mar; 22(3):403-8. PubMed ID: 17115196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nephrotic syndrome in African children: lack of evidence for 'tropical nephrotic syndrome'?
    Doe JY; Funk M; Mengel M; Doehring E; Ehrich JH
    Nephrol Dial Transplant; 2006 Mar; 21(3):672-6. PubMed ID: 16326742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein C and protein S in pediatric nephrotic patients.
    Yermiahu T; Shalev H; Landau D; Dvilansky A
    Sangre (Barc); 1996 Apr; 41(2):155-7. PubMed ID: 9045358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of P-glycoprotein in lymphocytes of children with nephrotic syndrome treated with glucocorticoids.
    Wasilewska AM; Zoch-Zwierz WM; Pietruczuk M
    Eur J Pediatr; 2006 Dec; 165(12):839-44. PubMed ID: 16738866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
    Aksu N; Türker M; Erdoğan H; Ozinel S; Kansoy S
    Turk J Pediatr; 1999; 41(2):225-30. PubMed ID: 10770662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-oxidant status in relation to lipoproteins, leptin and pro-inflammatory cytokines in children with steroid-sensitive nephrotic syndrome.
    Ece A; Atamer Y; Gürkan F; Bilici M; Koçyiğit Y
    Nephrology (Carlton); 2004 Dec; 9(6):366-73. PubMed ID: 15663638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation factors in nephrotic syndrome.
    Kanfer A
    Am J Nephrol; 1990; 10 Suppl 1():63-8. PubMed ID: 2256477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemostatic parameters in childhood nephrotic syndrome. (Is there any difference in protein C levels between steroid sensitive and resistant groups?).
    Yalçinkaya F; Tümer N; Gorgani AN; Ekim M; Cakar N
    Int Urol Nephrol; 1995; 27(5):643-7. PubMed ID: 8775051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased aggregation with normal surface charge and deformability of red blood cells in children with nephrotic syndrome.
    Böhler T; Linderkamp O; Leo A; Wingen AM; Schärer K
    Clin Nephrol; 1992 Sep; 38(3):119-24. PubMed ID: 1395161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemostasis and thromboembolism in children with nephrotic syndrome: differences from adults.
    Mehls O; Andrassy K; Koderisch J; Herzog U; Ritz E
    J Pediatr; 1987 Jun; 110(6):862-7. PubMed ID: 3585601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serum and urinary homocysteine in children with steroid-dependent nephrotic syndrome].
    Tenderenda E; Korzeniecka-Kozerska A; Porowski T; Wasilewska A; Zoch-Zwierz W
    Pol Merkur Lekarski; 2011 Oct; 31(184):204-8. PubMed ID: 22097175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenal responsiveness in children with steroid responsive idiopathic nephrotic syndrome.
    Hansen N; Stapleton FB; Roy S; Arant BS
    Int J Pediatr Nephrol; 1982 Mar; 3(1):1-4. PubMed ID: 6286520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemostatic variables in nephrotic patients.
    Cucuianu M; Manasia M; Spînu C; Trif I; Marcuşu C; Roman S; Rus HG
    Rom J Intern Med; 1991; 29(1-2):55-64. PubMed ID: 1844391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The treatment of children with idiopathic nephrotic syndrome using cyclosporin].
    Donckerwolcke RA; Vande Walle JG
    Ned Tijdschr Geneeskd; 1992 Sep; 136(36):1770-4. PubMed ID: 1407127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
    Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
    Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in WT1 in boys with sporadic isolated steroid-resistant nephrotic syndrome.
    Yang Y; Zhao F; Tu X; Yu Z
    Genet Mol Res; 2016 Mar; 15(1):15017559. PubMed ID: 26985958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of relapse in steroid-sensitive nephrotic syndrome: effect of stage of post-prednisone adrenocortical suppression.
    Leisti S; Koskimies O
    J Pediatr; 1983 Oct; 103(4):553-7. PubMed ID: 6312005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor XII and other hemostatic protein abnormalities in nephrotic syndrome patients.
    Thompson AR
    Thromb Haemost; 1982 Aug; 48(1):27-32. PubMed ID: 6813992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.